December 2, 2021 | Targeted Therapies in Oncology

Optimal Adjuvant and Neoadjuvant Regimens Are Explored in Lung Cancer

December 29, 2021

Clinical Articles

The most effective treatment strategy—adjuvant, neoadjuvant, or some combination of adjuvant plus neoadjuvant regimens— remains unclear. Ongoing trials are dedicated to defining the best sequence of treatment.

COVID-19 Continues On, Vaccinations Are Strongly Urged for All Patients With Cancer

December 20, 2021

Clinical Articles

In light of the continued risks of COVID-19, especially for immunocompromised patients and those with cancer, physicians and guidelines have recommended vaccination including booster shots as soon as possible for all patients with cancer.

Using a Biomarker-Driven Approach in TNBC

December 20, 2021

Clinical Articles

In using the biomarker approach to the treatment of triple-negative breast cancer, the challenge for the clinician is prioritizing the available treatment options based on the National Comprehensive Cancer Network guidelines for breast cancer, which focus on active agents, preferred single-agent chemotherapy approaches, and doublet options for certain patients at high risk.